Revenue segments as reported by the company.

Skin Care

Makeup

Fragrance

Hair Care

Other

Returns/charges associated with restructuring and other activities and adjustments

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Restructuring and other charges

Goodwill impairment

Impairment of other intangible assets

Talcum litigation settlement agreements

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Estee Lauder

Aveda is a company founded by Horst Rechelbacher, now owned by Estée Lauder Companies, headquartered in the Minneapolis suburb of Blaine, Minnesota. Aveda manufactures skin and body care, cosmetics, perfume, hair color, hair care products, and trains students in cosmetology, massage and esthiology at the Aveda Institutes in Minneapolis, New York City, Des Moines, Washington, DC, Maryland, Vancouver, Calgary, Orlando, Denver, Toronto and many other cities.

Aveda

Clinique is an American manufacturer of skincare, cosmetics, toiletries and fragrances, usually sold in high end department stores. It is a subsidiary of the Estée Lauder Companies.

Clinique

The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. It sells products under Estée Lauder, Clinique, Origins, MAC, Bobbi Brown, La Mer, Jo Malone London, Aveda and Too Faced. Its channels consist of department stores, multi-brand retailers, upscale perfumeries and pharmacies, and prestige salons and spas. The company was founded by Estee Lauder and Joseph Lauder in 1946 and is headquartered in New York, NY.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Estée Lauder reports Q1 earnings, addresses Asia travel retail challenges

Estée Lauder Companies faced challenges in Asia travel retail but demonstrated strength in global retail performance, particularly in key markets and skincare products. The company is focused on addressing inventory and supply chain volatility while aiming for double-digit growth in sales. Despite ongoing risks, the long-term importance of travel retail and recovery markets presents opportunities for the company.

Estee Lauder faces Q2 challenges but eyes growth in fiscal '24

Estee Lauder's Q2 2023 showed mixed results with declines in organic sales and adjusted EPS, but with bright spots in fragrance and certain markets.
Challenges in skin care and geographic variations were noted, alongside opportunities for margin expansion and growth in fiscal '24.
The company remains focused on strategic investments, including the acquisition of Tom Ford, to drive sustainable growth and navigate market dynamics.
Overall, Estee Lauder is adapting to evolving conditions, aiming for recovery in key segments and regions while preparing for future opportunities.

Estee Lauder faces Q3 challenges in Asia travel retail

Estee Lauder's Q3 2023 earnings call highlighted challenges in Asia travel retail impacting overall performance, leading to a decline in organic sales and adjusted diluted EPS. Despite these challenges, the company remains focused on rebuilding margins, investing in key markets, and driving innovation. Opportunities for growth are seen in the recovery of airport traffic and strategic initiatives in travel retail.

Estee Lauder aims for growth rebound in fiscal '24 amidst challenges

Estee Lauder's Q4 2023 saw organic sales growth driven by EMEA and Asia Pacific, but full-year sales declined due to Asia travel retail challenges. Fiscal '24 targets margin expansion and organic sales growth, with a focus on brand strength and market opportunities.
The company faces challenges in Asia travel retail and external market volatility, but remains optimistic about growth prospects. Strategic imperatives for fiscal '24 include driving growth in key markets, launching new products, and enhancing profitability.
Opportunities lie in leveraging brand strength, expanding in emerging markets like India, and improving travel retail performance. Efforts to enhance supply chain agility and balance value creation in retail collaborations are key focus areas for growth.

Estee Lauder Q1 2024: Mixed Results, Strategic Imperatives for Growth

Estee Lauder's Q1 2024 showed mixed results with challenges in travel retail but strengths in key markets like EMEA and Asia Pacific.
The company is focused on strategic imperatives for growth, cost efficiency, and sustainability, aiming to rebuild profitability.
Despite challenges, Estee Lauder remains confident in its fundamentals and brand portfolio for future growth opportunities.

Estee Lauder reports Q2 sales decline but exceeds EPS expectations

Estee Lauder is navigating a challenging sales environment but remains focused on profitability rebuild and long-term growth. The company is implementing a Profit Recovery Plan, expanding strategic initiatives globally, and aiming for a return to organic sales growth in key markets.

Estee Lauder reports strong Q3 earnings and outlines profit recovery plan

Estee Lauder's Q3 performance showcased strong sales growth in key regions, with a focus on operational efficiency and margin improvement.
The company's profit recovery plan aims to drive significant incremental operating profit through strategic initiatives and expense management.
Challenges in Mainland China and disruptions in retail sell-through were noted, but Estee Lauder remains optimistic about growth opportunities and market trends.
Analysts' inquiries focused on margin trends, spending shifts, and the pace of reinvestment, highlighting investor interest in Estee Lauder's financial strategies and market performance.

Estee Lauder addresses challenges, focuses on growth strategies for 2025

Estee Lauder's fiscal year 2024 was challenging, but the company is taking strategic actions to address issues and drive growth in fiscal year 2025. Despite expected sales challenges, Estee Lauder is focused on key growth areas and operational improvements to navigate market conditions.

Estee Lauder faces sales decline in Q1 2025 amidst market challenges

Estee Lauder navigated a challenging Q1 2025 with a sales decline and withdrawn outlook. Despite headwinds, the company showed strengths in key product categories and market share gains. Addressing cost pressures and strategic focus are crucial for future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Estee Lauder Cos. (EL) shares jumped Thursday after Bank of America Securities (BofA) analysts upgraded the stock and raised their price target for it, saying they see “meaningful growth” ahead for the beauty products maker.

Estee Lauder Gets Analyst Upgrade, Stock Takes Off

Ferrari

Luxury brand companies in the stock market specialize in selling high-end, quality products that command premium prices. Interestingly, the demand for these luxury items often increases as their prices rise.

3 Luxury Stocks Poised to Benefit from China's Economic Comeback

Estee Lauder Companies Inc (NYSE:EL, ETR:ELAA)'s expected rebound has prompted analysts at the Bank of America to upgrade their rating and boost their price target on the New York-headquartered cosmetics company. Describing the stock as a “Cinderella Story,” the analysts have upped their rating on the stock from ‘Neutral' to ‘Buy' and price target from $160 to $170.

Estée Lauder upgraded by analysts on ‘Cinderalla Story' upside

Amazon

Clinique will be the first Estée Lauder brand to be launched on Amazon. It is a major decision for the company who has long been reluctant to recognize any mass merchant retailer –including chain stores, Sephora, etc.

Estée Lauder Launches Clinique On Amazon

Some Estée Lauder Companies brands will open dedicated storefronts in the U.S. on Amazon's Premium Beauty destination over the coming months.  This rollout will start with Clinique, which announced its debut on the store in a Wednesday (March 27) press release.

Clinique Becomes First Estée Lauder Brand on Amazon Premium Beauty

AbbVie

AutoZone

Core Laboratories Inc

Compass Minerals

Corteva Inc

Etsy

Gilead Sciences

Honeywell

Hershey

International Flavors & Fragrances

Johnson & Johnson

Kenvue

McDonald's

MarketAxess Holdings

Motorola Solutions

NIKE

O'Reilly Automotive

Pfizer

Polaris

Philip Morris

Raytheon Technologies

Starbucks

Sysco

Teradyne

We share the heat map of the most investable candidates that may be worth your time for further analysis.

U.S. Wide-Moat Stocks On Sale - The March 2024 Heat Map

Booking Hlds

UnitedHealth Group

Zoetis

It is possible for retail investors to consistently beat the market by owning above-average blue chip dividend growth stocks. Hard work, research, and staying rational are key factors in outperforming the market. I highlight specific blue chip stocks, such as Booking Holdings, Zoetis, UnitedHealth Group, and Elevance Health, that have strong growth potential and attractive valuations.

You Don't Have To Take Excess Risk To Beat The Market

e.l.f. Beauty

LVMH Moet Hennessy Louis Vuitton

The beauty industry has been a source of some pretty gorgeous gains lately. As inflation begins to retreat, consumers may finally catch a break, with just a bit more disposable income in their products to spend on those nice-to-have discretionary items that bring them joy.

3 Beauty Stocks to Buy for Gorgeous Gains

SAN DIEGO--(BUSINESS WIRE)---- $EL #TheEsteeLauderCompaniesInc--Robbins LLP is Investigating the Officers and Directors of The Estee Lauder Companies Inc. (EL) on Behalf of Shareholders.

Robbins LLP is Investigating the Officers and Directors of The Estee Lauder Companies Inc. (EL) on Behalf of Shareholders

Estee Lauder (EL) is expanding its omnichannel capabilities to aid flexible and convenient shopping options for consumers. Management is on track to operationalize the Profit Recovery Plan.

Estee Lauder (EL) Gains On Online Sales & Profit Recovery Plan

Estée Lauder is making slow progress turning around its China business, making what used to be one of its biggest appeals the main source of concern for analysts.

Estée Lauder's Slow Progress on China Turnaround a Key Concern for Analysts

Estée Lauder (NYSE: EL) reported upbeat Q2'24 results last month (the fiscal year ends in June). The company's revenues stood at $4.3 billion and earnings came in at $0.88, well above the consensus estimates of $4.2 billion, and $0.34, respectively.

What's Next For Estée Lauder Stock After 10% Gains Post Q2 Results?

High levels of cancer-causing chemical benzene were detected in some acne treatments from brands including Estee Lauder‘s Clinique, Target‘s Up & Up, and Reckitt Benckiser-owned Clearasil, said independent U.S. laboratory Valisure.

Cancer-causing benzene was found in Clinique, Clearasil, and Target acne products

Estee Lauder (EL) reported earnings 30 days ago. What's next for the stock?

Estee Lauder (EL) Up 0.8% Since Last Earnings Report: Can It Continue?

Anheuser-Busch InBev

JD.com

Sensata Technologies Hld

Yum China Hlds

The stock market keeps hitting new record highs almost every week. With sectors like semiconductors and AI taking off, the sky is the limit.

Strong Buy Alert: Analysts Say to Scoop Up These 7 Stocks

The Estee Lauder Companies (EL) is on track to expand its reach across high-growth channels and push brands into new countries. However, persistent challenges in Mainland China hurt.

Estee Lauder's (EL) Online & Emerging Market Sales Aid Growth

NEW YORK--(BUSINESS WIRE)--Fabrizio Freda, President and Chief Executive Officer, and Jane Hertzmark Hudis, Executive Group President, of The Estée Lauder Companies Inc. (NYSE: EL) will participate in the UBS Global Consumer and Retail Conference in New York on Thursday, March 14, 2024, at 9:00 a.m. ET. Interested parties can access the live webcast of the fireside chat on Thursday, March 14th from 9:00 a.m. – 9:45 a.m. ET at http://www.elcompanies.com/investors. The webcast will be archived on.

The Estée Lauder Companies to Participate in the UBS Global Consumer and Retail Conference

Mondelez

Honda

Taiwan Semiconductor Manufacturing

The stock market is an interesting place at the moment, with some heralding 2024 as the ‘year of equities' and others sure that a United States stock market crash is imminent.

Seven criminally undervalued stocks to watch in March 2024: Part one

PARIS , Feb. 27, 2024 /PRNewswire/ -- BALMAIN BEAUTY unveils "Projet Confidentiel," a campaign teasing the brand's luxury fragrance experience launching September 2024. Ahead of the Balmain fashion show on February 28, 2024, the Projet Confidentiel campaign debuts a series of striking assets featuring a matte black unlabeled fragrance bottle flanked by the iconic Balmain PB logo.

BALMAIN BEAUTY TEASES LUXURY FRAGRANCE EXPERIENCE LAUNCHING SEPTEMBER 2024

Coty

Helen of Troy

Inter Parfums

The Zacks Cosmetics industry companies are benefiting from a burgeoning demand for skincare and personal care products. Focus on innovations is propelling The Estee Lauder Companies (EL), COTY, Inter Parfums (IPAR) and Helen of Troy (HELE).

4 Cosmetics Stocks Worth Watching on Robust Industry Trends

British American Tobacco

Realty Income Corp

PayPal

U.S. indices are hitting new all-time highs seemingly every week. Traders are enthusiastic, but some analysts are warning of a potential market bubble.

Wall Street Favorites: 7 Long-Term Stocks With Strong Buy Ratings for February 2024

Allstate

Investors are understandably jazzed about Nvidia's upcoming earnings report for last year. But analysts think a surprisingly large number of companies will grow even faster this year.

8 Companies' Profit Is Expected To Outgrow Even Nvidia's This Year

News for Estee Lauder Stock (EL)